Law W M, Wahner H W, Heath H
Mayo Clin Proc. 1984 Dec;59(12):811-5. doi: 10.1016/s0025-6196(12)65614-6.
To determine whether familial benign hypercalcemia, or familial hypocalciuric hypercalcemia (FHH), has adverse effects on the skeleton, we measured bone mineral density (BMD) in 31 affected persons from 14 families (16 women and 15 men), ranging in age from 19 to 68 years. Forearm BMD was measured by single-photon absorptiometry, and spinal BMD was measured by dual-photon absorptiometry. In addition, we systematically queried 82 hypercalcemic and 52 normocalcemic family members about skeletal fractures. Both men and women with FHH had normal BMD (expressed as grams per square centimeter) in the lumbar spine, distal radius, and midradius. Osteoporotic-type fractures (vertebrae, hip, and distal radius) were virtually absent in both affected and unaffected family members. Detailed evaluation of larger numbers of of older affected persons may be necessary to resolve this issue definitively, but we conclude provisionally that FHH has no important adverse effects on skeletal health.
为了确定家族性良性高钙血症,即家族性低钙尿性高钙血症(FHH)是否对骨骼有不良影响,我们测量了来自14个家庭的31名患者(16名女性和15名男性)的骨矿物质密度(BMD),年龄范围在19至68岁之间。通过单光子吸收法测量前臂骨密度,通过双光子吸收法测量脊柱骨密度。此外,我们系统地询问了82名高钙血症家族成员和52名血钙正常的家族成员有关骨骼骨折的情况。患有FHH的男性和女性在腰椎、桡骨远端和桡骨中段的骨密度(以每平方厘米克数表示)均正常。在受影响和未受影响的家族成员中,骨质疏松型骨折(椎骨、髋部和桡骨远端)几乎不存在。可能需要对更多数量的老年患者进行详细评估才能最终解决这个问题,但我们初步得出结论,FHH对骨骼健康没有重要的不良影响。